Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 BIOCON    ACTAVIS
EQUITY SHARE DATA
    BIOCON
Mar-23
ACTAVIS
Dec-18
BIOCON /
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs38816,159-   
Low Rs19210,840-   
Sales per share (Unadj.) Rs93.13,963.8-  
Earnings per share (Unadj.) Rs5.4-1,276.8-  
Cash flow per share (Unadj.) Rs14.6417.7-  
Dividends per share (Unadj.) Rs1.500-  
Avg Dividend yield %0.50-  
Book value per share (Unadj.) Rs146.516,349.0-  
Shares outstanding (eoy) m1,200.60332.60-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.13.4 91.4%   
Avg P/E ratio x54.1-10.6 -511.6%  
P/CF ratio (eoy) x19.832.3 61.3%  
Price / Book Value ratio x2.00.8 239.4%  
Dividend payout %28.00-   
Avg Mkt Cap Rs m347,8144,489,898 7.7%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m21,8100-   
Avg. sales/employee Rs Th078,010.2-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0-25,127.1-  
INCOME DATA
Net Sales Rs m111,7421,318,372 8.5%  
Other income Rs m7,68125,212 30.5%   
Total revenues Rs m119,4231,343,584 8.9%   
Gross profit Rs m16,61134,548 48.1%  
Depreciation Rs m11,131563,576 2.0%   
Interest Rs m4,19076,078 5.5%   
Profit before tax Rs m8,971-579,893 -1.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0147,896 0.0%   
Tax Rs m2,541-7,349 -34.6%   
Profit after tax Rs m6,430-424,648 -1.5%  
Gross profit margin %14.92.6 567.3%  
Effective tax rate %28.31.3 2,235.1%   
Net profit margin %5.8-32.2 -17.9%  
BALANCE SHEET DATA
Current assets Rs m123,340540,727 22.8%   
Current liabilities Rs m85,107478,345 17.8%   
Net working cap to sales %34.24.7 723.1%  
Current ratio x1.41.1 128.2%  
Inventory Days Days12920 658.8%  
Debtors Days Days11766 176.0%  
Net fixed assets Rs m394,078149,232 264.1%   
Share capital Rs m6,0030-   
"Free" reserves Rs m169,9260-   
Net worth Rs m175,9295,437,670 3.2%   
Long term debt Rs m152,9051,914,801 8.0%   
Total assets Rs m517,4188,500,316 6.1%  
Interest coverage x3.1-6.6 -47.4%   
Debt to equity ratio x0.90.4 246.8%  
Sales to assets ratio x0.20.2 139.2%   
Return on assets %2.1-4.1 -50.1%  
Return on equity %3.7-7.8 -46.8%  
Return on capital %4.0-4.8 -82.7%  
Exports to sales %3.10-   
Imports to sales %6.00-   
Net fx Rs m-3,1870-   
CASH FLOW
From Operations Rs m18,525471,005 3.9%  
From Investments Rs m-142,818258,756 -55.2%  
From Financial Activity Rs m130,487-808,385 -16.1%  
Net Cashflow Rs m6,411-78,232 -8.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 83.51 Rs / USD

Compare BIOCON With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare BIOCON With: BETA DRUGS   VINEET LABORATORIES  SHELTER PHARMA  ALBERT DAVID  DISHMAN CARBOGEN AMCIS  



Today's Market

Sensex Today Falls 1,000 Points from Day's High, Slides for 4th Day | Nifty Below 22,100 | Infosys, Bajaj Auto Surge Ahead of Q3 Results Sensex Today Falls 1,000 Points from Day's High, Slides for 4th Day | Nifty Below 22,100 | Infosys, Bajaj Auto Surge Ahead of Q3 Results(Closing)

It was indeed a volatile trading session for Indian share markets today. Benchmark indices swung between gains and losses throughout the day.